Contact Aspiration Versus Stent Retriever for Recanalisation of Acute Stroke Patients With Basilar Artery Occlusion: The Posterior Circulation ASTER Randomized Trial Protocol

Not Applicable

Recruiting

• Conditions: Basilar Artery Occlusion
• Interventions: Procedure: Contact aspiration Thrombectomy; Procedure: Stent retriever thrombectomy

• Registration Number: NCT05320263
• Lead Sponsor: Hopital Foch

Brief Summary

Acute ischemic stroke (AIS) patients with basilar artery occlusion (BAO) present a devastating, life-threatening prognosis.

Urgent recanalization with endovascular mechanical thrombectomy is routinely performed in patients with BAO although the level of evidence is lower than that in anterior circulation occlusions (randomization in this population versus medical treatment alone having been impossible in recent studies). Recently, a large retrospective study supports the interest of thrombectomy in this population .

Speed and grade of the recanalisation have a major impact on clinical outcome. Favorable outcome at 90 days is strongly associated with the successful recanalization status at the end of the endovascular procedure (OR=4.57, 95%CI=1.24-16.87, P=0.023).

First pass effect has been shown to be a strong marker of efficacy of endovascular procedure with significant correlation with clinical outcome.

Thrombectomy with Stent retrievers dramatically changed the prognosis of anterior circulation large vessel occlusion strokes and currently used in BAO patients (posterior circulation). Contact aspiration (CA) is currently used in anterior large vessel occlusions (COMPASS trial, Lancet 2019), with similar rates of recanalization and favorable outcomes (Boulanger M, 2019), as well as in BAO patients .

However, the benefit of CA compared to SR for the treatment of BAO remains under debate with the superiority of first line CA compared to SR or no difference. Available data are based on retrospective studies with no data from RCT.

In this context, a randomized controlled trial is needed to assess the benefit of CA versus SR.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2022-02-14
• Study First Submitted QC: 2022-04-01
• Study First Posted: 2022-04-11
• Study Start: 2022-11-19
• Status Verified: 2023-02
• Last Update Submitted: 2023-02-27
• Last Update Posted: 2023-03-01
• Primary Completion: 2026-07
• Study Completion: 2027-07

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 480

Inclusion Criteria

Age ≥ 18 years

• AIS with BAO on non-invasive imaging (CT or MRI)
• Eligible for thrombectomy : groin puncture undergone within 24 hours of first symptoms or of last time the patient was seen normal
• Being covered by a national health insurance
• Informed consent obtained from the patients/his proxy or following an emergency procedure

Read More

Exclusion Criteria

• Known or suspected pre-existing (chronic) large vessel stenosis / occlusion in the symptomatic territory (basilar artery)
• Severe contrast medium allergy or absolute contraindication to use of iodinated products
• Clinical history, past imaging or clinical judgment suggesting intracranial stenosis of the basilar artery
• Pregnancy (urine or serum beta HCG test for women of child-bearing potential)
• Person deprived of liberty
• Patient benefiting from a legal protection (guardianship or curatorship)

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
contact aspiration first line thrombectomy	Contact aspiration Thrombectomy	Patient randomized in this arm will have the first arm thrombectomy by contact aspiration
Stent retriever first line thrombectomy	Stent retriever thrombectomy	Patient randomized in this arm will have the first arm thrombectomy by Stent retriever

Primary Outcome Measures

Name	Time	Method
Rate of first pass effect (FPE) defined by complete reperfusion after first device pass	24 hours	The definition of FPE: single pass/use of the device, (2) complete revascularization of the large vessel occlusion and its downstream territory (mTICI 3), and (3) no use of rescue therapy

Secondary Outcome Measures

Name	Time	Method
Rate of complete reperfusion after first-line thrombectomy strategy and at the end of endovascular procedure	24 hours	mTICI (modified Thrombolysis In Cerebral Infarction ) score equals to 3 after the first line thrombectomy and at the end of endovascular.; mTICI score is evaluated between 0-3 : 0 a complete obstruction of the artery and 3 indicates a complete reperfusion
Rate of successful reperfusion (mTICI 2b/2c/3) after first-line thrombectomy strategy and at the end of endovascular procedure	24 hours	mTICI score is evaluated between 0 to 3. Rate of patients with mTICI score equals to 2b/2c/3 after first-line thrombectomy strategy and at the end of endovascular procedure will be evaluated.
Rate of near to complete reperfusion (mTICI 2c/3) after first-line thrombectomy strategy and at the end of endovascular procedure	24 hours
Rate of Arterial Occlusive Lesion (AOL) recanalization score III after first-line thrombectomy strategy and at the end of endovascular procedure	24 hours	AOL recanalization score is evaluated between 0 to 3 : * 0 indicates no recanalization of the primary occlusive lesion; * 3 indicates complete recanalization of the primary occlusive lesion with any distal flow
Groin puncture time to successful reperfusion time (evaluated in minutes)	360 minutes
Modified Rankin Score (mRS) at 3 and 12 months	12 months	mRS is evaluated between 0 to 6. A score of 0 indicates that there is no disability and a score of 6 indicates death.
Rate of good functional outcome at 90-day and at one year defined by a mRS 0-3 or equal to pre-stroke mRS (Modified Rankin Score)	12 months
Quality of life at 90 days and 12 months assessed by EuroQol 5D-5L scale	12 months	EuroQol 5D-5L comprises five dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/depression. Each dimension has 5 levels: no problems, slight problems, moderate problems, severe problems and extreme problems. The patient is asked to indicate his/her health state by ticking the box next to the most appropriate statement in each of the five dimensions. This decision results in a 1-digit number that expresses the level selected for that dimension. The digits for the five dimensions can be combined into a 5-digit number that describes the patient's health state.
All cause of mortality at 90-day and 12 months	12 months
24-hours change in NIHSS (National Institutes of Health Stroke Scale) from baseline defined as the difference between NIHSS score at 24 hours and NIHSS score at admission.	24 hours	NIHSS (National Institutes of Health Stroke Scale) score is evaluated between 0-42 0 is normal and 42 maximal gravity
Subgroups analysis : Age (≤70 vs. >70 years)	24 hours
Subgroups analysis :Baseline NIHSS≥10 vs NIHSS<10 (18)	24 hours
Subgroups analysis : Volume of infarct area assessed by pc-ASPECTS (≤7 vs. >7)	24 hours	A pc-ASPECTS score of 10 indicates absence of visible ischemic changes in the posterior circulation, and pc-ASPECTS score of 0 indicates ischemic changes in the midbrain, pons, and bilateral thalami, posterior circulation territories, and cerebellar hemispheres
Subgroups analysis : Time from admission of patient in hospital to randomization (≤ 300 vs. > 300 minutes)	360 minutes
Subgroups analysis: Baseline site of thrombi on vascular imaging (Top of the basilar artery vs other adjudicated by the core lab)	24 hours
Subgroups analysis: Prior use of IV alteplase (yes vs. no)	24 hours
Subgroups analysis : Collateral status (good versus poor, as adjudicated by the core lab on initial angiogram) with a 0-3 scale	24 hours	Collateral circulation is estimated by angiography with a 0-3 scale. The collateral status will be categorized as poor collaterals (scores 0-1) and good collaterals (scores 2-3)
Incidence of any intracerebral hemorrhage (ICH), parenchymal hematoma (PH), symptomatic ICH on brain imaging (Magnetic resonance imaging MRI or CT (computed tomography) scan) at 24±12h after thrombectomy (according to ECASS3 classification)	24 hours	ECASS III (European Cooperative Acute Stroke Study) classification : * Hemorrhage infarction type 1 (HI1); * Hemorrhage infarction type 2 (HI2); * Parenchymal hematoma type 1 (PH1); * Parenchymal hematoma type 2 (PH2)
Incidence of procedure-related complications defined as arterial perforation, arterial dissection, embolization in a new territory (ENT) and subarachnoid haemorrhage	hours
Cost-effectiveness analysis at 12 months	12 months	Incremental cost-effectiveness ratio (ICER, cost per quality-adjusted life year \[QALY\]), of Contact Aspiration (CA) first-line thrombectomy compared to standard first-line SR thrombectomy in treatment of AIS due to BAO, from a collective perspective and with a 12-months' time horizon.

Trial Locations

Locations (12)

Chu Nantes; 🇫🇷 Nantes, France

APHP - Pitié Salpêtrière; 🇫🇷 Paris, France

CHU Caen; 🇫🇷 Caen, France

CHU de Reims; 🇫🇷 Reims, France

CHU Rennes; 🇫🇷 Rennes, France

Chu Bordeaux; 🇫🇷 Bordeaux, France

Chru Nancy; 🇫🇷 Nancy, France

CHU Limoges; 🇫🇷 Limoges, France

Hôpital FOCH; 🇫🇷 Suresnes, France

Fondation Adolphe de Rothschild; 🇫🇷 Paris, France

CHU Montpellier; 🇫🇷 Montpellier, France

CHU de Tours; 🇫🇷 Tours, France